$14.1MSeries D, 3 March 2026
Completes phase 2 of blood cancer therapy TC011 and moves TC091 into phase 1
- Amount
- $14.1M
- Stage
- Series D
- Announced
- 3 March 2026
- Lead
- SJ Investment Partners
- Other investors
- Kiwoom Securities, IM Investment Partners
- Use of funds
- Completes phase 2 of blood cancer therapy TC011 and moves TC091 into phase 1
- Checked
- Amount and date matched across 2 press sources
- Sources
- Tcaros raises ₩20.8B Series D (date approx) unicornfactory.co.kr
Tcaros raises ₩20.8B Series D (date approx) startuprecipe.co.kr